sábado, 10 de octubre de 2020

Bharat Biotech asked to submit complete ph 2 data of its COVID-19 vaccine before ph 3 trial | India News,The Indian Express

Bharat Biotech asked to submit complete ph 2 data of its COVID-19 vaccine before ph 3 trial | India News,The Indian Express

COVID-19 Vaccine, Coronavirus Vaccine

Bharat Biotech asked to submit complete ph 2 data of its COVID-19 vaccine before ph 3 trial



The company has applied to the Drugs Controller General of India (DCGI) on October 2, seeking its permission to conduct phase-3 randomised double-blind placebo-controlled multicentre trial of its COVID-19 vaccine candidate.

No hay comentarios:

Publicar un comentario